Marpai, Inc. (MRAI)
OTCMKTS · Delayed Price · Currency is USD
2.230
+0.020 (0.90%)
At close: Jul 31, 2026
Marpai Revenue
Marpai had revenue of $4.44M in the quarter ending March 31, 2026, a decrease of -17.98%. This brings the company's revenue in the last twelve months to $17.13M, down -34.65% year-over-year. In the year 2025, Marpai had annual revenue of $18.10M, down -35.76%.
Revenue (ttm)
17.13M
Revenue Growth
-34.65%
P/S Ratio
3.30
Revenue / Employee
160.05K
Employees
107
Market Cap
56.49M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 18.10M | -10.07M | -35.76% |
| Dec 31, 2024 | 28.17M | -8.98M | -24.17% |
| Dec 31, 2023 | 37.16M | 12.81M | 52.64% |
| Dec 31, 2022 | 24.34M | 10.12M | 71.10% |
| Dec 31, 2021 | 14.23M | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 594.41M |
| Sofgen Pharma | 373.80M |
| Elite Pharmaceuticals | 148.87M |
| BioStem Technologies | 37.65M |
| Veri Medtech Holdings | 10.01M |
| BioScience Health Innovations | 5.21M |
| Nuo Therapeutics | 4.13M |
| Silence Therapeutics | 839.00K |
Marpai News
- 3 days ago - Marpai Announces $12 Million Private Placement led by Mitchell Companies - PRNewsWire
- 13 days ago - Marpai Inc. Announces Debt Restructuring Agreements with JGB Capital and AXA, Reducing Debt Service by $26.4 Million Through 2027 and Enhances Near term Liquidity - PRNewsWire
- 2 months ago - Marpai Inc. Announces Unprecedented Growth with 192,000 New Estimated Member Lives Across TPA and MarpaiRx PBM Platforms; Expects to Achieve Positive Cash Flow and EBITDA Beginning August 2026 - PRNewsWire
- 2 months ago - MARPAI REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS - PRNewsWire
- 2 months ago - Marpai Quarterly report: Q1 2026 - Filings
- 2 months ago - Marpai, Inc. Announces Significant New Business Wins across TPA and MarpaiRx; Solidifies Forecast for Profitability - PRNewsWire
- 4 months ago - Marpai, Inc. Secures Major Strategic Marketing Collaboration to Continue Acceleration of MarpaiRx Growth Nationwide - PRNewsWire
- 5 months ago - Marpai Secures Access to Network Creating Major Growth Catalyst for MarpaiRx Representing Up to 1.5 million Covered Lives - PRNewsWire